Vimarsana
Biggest News Aggregation in the World

Page 32 - Chumakov News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chumakov. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chumakov Today - Breaking & Trending Today

CoviVac vaccine can be effective against all coronavirus mutations — developer - Vimarsana News

CoviVac vaccine can be effective against all coronavirus mutations — developer

CoviVac vaccine can be effective against all coronavirus mutations — developer As of April 16, more than 190 cases of the British coronavirus strain and more than 20 cases of the South African strain were registered in Russia MOSCOW, April 20. /TASS/. The CoviVac coronavirus vaccine developed by the Chumakov Federal Scientific Center for Research and Development of Immune and Biological Products at the Russian Academy of Sciences can be effective against all currently known coronavirus mutations as it is based on whole virus antigens, Aidar Ishmukhametov, the Center;s director general an...

Source: tass.com
Covid-19 causes twice as many complications as flu, Russian health minister says - Vimarsana News

Covid-19 causes twice as many complications as flu, Russian health minister says

According to Mikhail Murashko, vaccination will help avoid not only infection but also serious complications © Alexander Astafiev/POOL/TASS MOSCOW, April 10. /TASS/. Covid-19 causes twice as many complications as seasonal influenza and other respiratory diseases, so, vaccination will help avoid not only infection but also serious complications, Russian Health Minister Mikhail Murashko said on Saturday. "The novel coronavirus infection has practically twice as many complications, neurological, including psychiatric, as seasonal flu and other acute respiratory diseases. Vaccination is what h...

Source: tass.com
EpiVacCorona effective against British, South African coronavirus strains — expert - Vimarsana News

EpiVacCorona effective against British, South African coronavirus strains — expert

EpiVacCorona effective against British, South African coronavirus strains — expert The researcher said should new coronavirus strains emerge, it would be possible to promptly modify the vaccines accordingly © Donat Sorokin/TASS MOSCOW, April 7. /TASS/. Russia’s vaccine EpiVacCorona is effective against the British and South African mutations of the novel coronavirus, the chief of Vector's Yekaterinburg Research Institute of Viral Infections, Alexander Semyonov said on the Vesti FM radio station. Read also "This vaccine [EpiVacCorona] works against all strains that exist, that are kn...

Source: tass.com
Kremlin says number of those willing to get vaccinated against Covid-19 growing rapidly - Vimarsana News

Kremlin says number of those willing to get vaccinated against Covid-19 growing rapidly

Kremlin says number of those willing to get vaccinated against Covid-19 growing rapidly The Kremlin spokesman said that it might be a result of a quite vigorous advertising campaign in the mass media © Sergei Bobylev/TASS MOSCOW, April 5. /TASS/. The number of Russians willing to get vaccinated against the coronavirus infection is growing quite rapidly, Russian president’s press secretary Dmitry Peskov said on Monday. Read also "Indeed, the number of those willing to get vaccinated is growing quite rapidly," he said, adding that it might be a result of a quite vigorous advertising campai...

Source: tass.com
Latest: Johnson & Johnson expands vaccine trials to adolescents age 12 to 17 - Vimarsana News

Latest: Johnson & Johnson expands vaccine trials to adolescents age 12 to 17

Email Johnson & Johnson says it has expanded its phase 2a clinical trial to include young people age 12 to 17. The FDA has also said that Moderna’s vaccine can be stored at room temperature for up to a day and that the company can include extra doses in its vials. These changes could help speed up distribution of the vaccine. COVID-19 vaccines have reached consumers in record time. Though the process can typically take 10 to 15 years, the U.S. Food and Drug Administration has granted emergency authorization to vaccines made by Pfizer, Moderna, and Johnson & Johnson in less than a year. Befo...